Actively Recruiting
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-12
300
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and/or therapeutic escalation.
CONDITIONS
Official Title
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 16 years old or older
- Diagnosis of juvenile idiopathic arthritis with specialized rheumatology follow-up at Cochin Hospital
- No opposition to participating in the research
- Patient has health insurance
- Ability to understand and communicate in French
You will not qualify if you...
- Under curatorship or guardianship
- Receiving French state medical aid
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rheumatology Department, Cochin Hospital
Paris, IDF, France, 75014
Actively Recruiting
Research Team
Y
Yannick ALLANORE, PD, PhD
CONTACT
M
Marie BENHAMMANI-GODARD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here